Orange Book product · Brand (NDA)
SYPRINE
TRIENTINE HYDROCHLORIDE
At a glance
Nov 08, 1985
Approved
Brand (NDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 08, 1985
41 yr 2 mo ago
Today
Pharmaceutical detail
Active ingredient
TRIENTINE HYDROCHLORIDE
Strength
250MG
Dosage form
CAPSULE
Route
ORAL
TE code
AB
Application
NDA 019194
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2022TRIENTINE HYDROCHLORIDEGeneric (ANDA)
ANDA 216356 · HETERO LABS LTD III
- 2021TRIENTINE HYDROCHLORIDEGeneric (ANDA)
ANDA 212929 · ACCORD HLTHCARE
- 2021TRIENTINE HYDROCHLORIDEGeneric (ANDA)
ANDA 209945 · ECI PHARMS LLC
- 2020TRIENTINE HYDROCHLORIDEGeneric (ANDA)
ANDA 211637 · LUPIN
- 2020TRIENTINE HYDROCHLORIDEGeneric (ANDA)
ANDA 212238 · RISING
- 2019CLOVIQUEGeneric (ANDA)
ANDA 209731 · CHARTWELL RX
- 2019TRIENTINE HYDROCHLORIDEGeneric (ANDA)
ANDA 210096 · PH HEALTH
- 2019TRIENTINE HYDROCHLORIDEGeneric (ANDA)
ANDA 209415 · CHARTWELL RX
- 2019TRIENTINE HYDROCHLORIDEGeneric (ANDA)
ANDA 211076 · DR REDDYS
- 2019TRIENTINE HYDROCHLORIDEGeneric (ANDA)
ANDA 211134 · MSN
- 2019TRIENTINE HYDROCHLORIDEGeneric (ANDA)
ANDA 211554 · ZYDUS PHARMS
- 2019TRIENTINE HYDROCHLORIDEGeneric (ANDA)
ANDA 210619 · AMNEAL
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
